镰状细胞病
危机预防
中文简体(普通话)
危机预防
/assets/ct/b025754cdb/images/syn_placeholder_sqr.png

镰状细胞病

危机预防

药物诱导胎儿血红蛋白

Safety of hydroxyurea in pregnancy: a systematic review of the literature. (打开新窗口)

Al Sulaimani R, Zitoun N, Alothman H, Hutson JR, Garcia-Bournissen F

来源‎: J Obstet Gynaecol Can. 2025 Jul;47(7):102924.

检索‎: PubMed 40381805

DOI码‎: 10.1016/j.jogc.2025.102924

https://pubmed.ncbi.nlm.nih.gov/40381805/ (打开新窗口)

Outcomes of pregnancies in sickle cell patients treated with hydroxyurea : findings from the escort-HU cohort studies. (打开新窗口)

Anoosha Habibi, Maryse Etienne-Julan, Maria Dimopoulou, Gylna Loko, Pagona Flevari, Narcisse Elenga, Sylvain LE Jeune, Estelle Jean, Laura Thomas-Bourgneuf, Jean-Benoit Arlet, Stephanie NGO, Emmanuelle Bernit, Corinne Charneau, Justine Dautremer, Laure Joseph, Giovanna Cannas, Pablo Bartolucci

来源‎: Blood 2025;146(Suppl 1):2-3.

检索‎: DOI

DOI码‎: 10.1182/blood-2025-2

https://ashpublications.org/blood/article/146/Supplement%201/2/553643/Outcomes-of-pregnancies-in-sickle-cell-patients (打开新窗口)

Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (打开新窗口)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

来源‎: Ann Intern Med 2008;148(12):939-55.

检索‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (打开新窗口)

Hydroxyurea for the treatment of sickle cell anemia. (打开新窗口)

Platt OS.

来源‎: N Engl J Med 2008;358(13):1362-9.

检索‎: PubMed 18367739

DOI码‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (打开新窗口)

Clinical effectiveness of decitabine in severe sickle cell disease. (打开新窗口)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

来源‎: Br J Haematol 2008;141(1):126-9.

检索‎: PubMed 18324975

DOI码‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (打开新窗口)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (打开新窗口)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

来源‎: Blood 2010;115(12):2354-63.

检索‎: PubMed 19903897

DOI码‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (打开新窗口)

预防感染和其他并发症

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (打开新窗口)

Hirst C, Owusu-Ofori S.

来源‎: Cochrane Database Syst Rev 2012;(9):CD003427.

检索‎: PubMed 22972063

DOI码‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (打开新窗口)

Sickle cell disease. (打开新窗口)

Meremikwu MM, Okomo U.

来源‎: BMJ Clin Evid 2011;02:2402.

检索‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (打开新窗口)

A phase 3 trial of l-glutamine in sickle cell disease. (打开新窗口)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

来源‎: N Engl J Med 2018;379(3):226-35.

检索‎: PubMed 30021096

DOI码‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (打开新窗口)

Malaria chemoprophylaxis in sickle cell disease. (打开新窗口)

Oniyangi O, Omari AA.

来源‎: Cochrane Database Syst Rev 2006;(4):CD003489.

检索‎: PubMed 17054173

DOI码‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (打开新窗口)